Why Semaglutide is an inflection point for India’s generics sector?
⚡ Quick Summary
More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for India’s pharmaceutical industry, which supplies about 20% of the world’s generic medicines by volume.
📰 Related Articles
Nashik family outing turns violent; nine detained
The Hindu
How India’s first educational computer arrived on a bullock cart
The Hindu
Punjab Assembly resolution seeks ban on social media accounts of kids under 16
Dawn Pakistan
Three middlemen arrested for bringing illegal Bangladeshi immigrants to Mangaluru
The Hindu
Court remands journalist, Stanley Ugagbe, in prison over cyberstalking charges
Premium Times